Finance

Beta
Lists
ERNA:NASDAQ
Ernexa Therapeutics Inc
$6.97
-5.81%
(-0.43) 1D
Jun 26, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ERNA...
Open
$6.91
High
$7.23
Low
$5.16
Mkt. cap
8.13M
Avg. vol.
189.10K
Volume
81.26K
52-wk high
$71.50
52-wk low
$3.18
EPS
-$30.48
Beta
2.49
Shares outstanding
1.17M
No. of employees
5
Open
$6.91
High
$7.23
Low
$5.16
Mkt. cap
8.13M
Avg. vol.
189.10K
Volume
81.26K
52-wk high
$71.50
52-wk low
$3.18
EPS
-$30.48
Beta
2.49
Shares outstanding
1.17M
No. of employees
5
News stories
From sources across the web
About Ernexa Therapeutics Inc
CEO-
Employees5
Founded2018
HeadquartersBrooklyn, New York, United States
SectorBiotechnology
Websiteernexatx.com
Analyst ratings
Based on 1 analyst giving stock ratings to ERNA in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12-month forecast
Based on 1 Wall Street analyst offering 12-month price targets for ERNA in the last 3 months
Highest
Current $6.97
$30.00 (+330.42%)
Average
$30.00 (+330.42%)
Lowest
$30.00 (+330.42%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kumaraguru Raja
Brookline Capital Markets
Buy
Initiated
$30.00
+330.4%
05/07/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.14M
1.04M
676.00K
1.92M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.36M
958.00K
1.42M
1.63M
Operating expense
2.50M
1.99M
2.09M
3.55M
Total operating expenses
2.50M
1.99M
2.09M
3.55M
Operating income
-2.50M
-1.99M
-2.09M
-3.55M
Other non operating income
-635.00K
-6.00K
479.00K
-
EBT including unusual items
-3.14M
-1.23M
-1.56M
-5.55M
EBT excluding unusual items
-3.14M
-1.97M
-1.60M
-3.50M
Income tax expense
3.00K
6.00K
-62.00K
-40.00K
Effective tax rate
-0.10%
-0.49%
3.96%
0.72%
Other operating expenses
-
-
-
-
Net income
-3.14M
-1.24M
-1.50M
-5.51M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
31.00K
47.00K
44.00K
Interest expense
-
-
-27.00K
-
Net interest expenses
-
31.00K
20.00K
44.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.48M
-1.98M
-2.08M
-3.54M
Gain or loss from assets sale
-
13.00K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of ERNA
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer